Skip to content
S9838Senate2023-2024 SessionSame asA7954

Import Cheaper Prescription Drugs

Official title

“Relates to creating a wholesale prescription drug importation program”

Sponsor James SkoufisSD-42Affects Education
Status
Assembly Floor Calendar
Impact
8/10
Significant
Passage
0%

Bill progress

Step 5 of 7

In Assembly · Higher Education

What's happening

This bill creates a program for importing wholesale prescription drugs from Canada to New York to lower consumer costs.

Why it matters

  1. Strict Safety & Oversight Measures. The program mandates that only drugs meeting U.S. FDA safety, effectiveness, and labeling standards can be imported, and explicitly excludes controlled substances, biologics, and certain high-risk drugs, aiming to protect consumers from unsafe or counterfeit medications.

  2. Transparency & Accountability. Wholesalers participating in the program must provide detailed tracking and tracing information for each batch of imported drugs (including origin, destination, and price paid), and the state will conduct regular audits to ensure genuine cost savings and regulatory compliance.

  3. Limited Scope & Federal Compliance. The program cannot proceed without federal approval and must comply with all federal laws, including 21 U.S.C. § 384. If violations occur, the state can immediately suspend importation for specific drugs or wholesalers, prioritizing public health and legal compliance.

  4. Potential Impact on Public Drug Programs. The bill includes provisions to allow entities in the federal 340B drug discount program to participate without jeopardizing their federal benefits, potentially increasing access to lower-cost drugs for safety-net providers and their patients.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Import Cheaper Prescription Drugs

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
James Skoufis

Senator · Senate District 42

Chair, Investigations And Government Operations

No co-sponsors yet.

History

  1. Ordered to third reading rules cal.612
  2. Substituted for A7954A
  3. Referred to higher education
  4. Delivered to assembly
  5. Passed senateVote 59–2
  6. Ordered to third reading cal.1877
  7. Referred to rules

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A7954Assembly

Import Prescription Drugs from Canada

Assembly Floor Calendar · Sponsor Jo Anne Simon

Impact 8 · Significant0% to pass

Full text

3 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

9838

IN SENATE

June 3, 2024

Introduced by Sen. SKOUFIS -- read twice and ordered printed, and when printed to be committed to the Committee on Rules

AN ACT to amend the public health law and the education law, in relation to creating a wholesale prescription drug importation program

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. The public health law is amended by adding a new section 280-d to read as follows:

§ 280-d. Wholesale prescription drug importation program. 1. As used in this section, the following terms shall have the following meanings:

(a) "Wholesale prescription drug importation program" or "program" means the wholesale prescription drug importation program created under this section.

(b) "Prescription drug wholesaler" means an entity authorized to acquire prescription drugs and sell or distribute them wholesale in the state.

(c) "Approved wholesaler" means a prescription drug wholesaler authorized to participate in the importation program under this section pursuant to approval by the state education department under section sixtyeight hundred eight of the education law.

2. The commissioner, in consultation with the commissioner of education and other appropriate federal and state agencies, shall design a wholesale prescription drug importation program for the wholesale importation of prescription drugs from Canada. The program design shall comply with applicable federal requirements, including 21 U.S.C. § 384, and requirements regarding safety and cost savings. Under the program design:

(a) prescription drugs shall only be acquired from Canadian prescription drug suppliers regulated and authorized under the laws of Canada or one or more Canadian provinces, or both;

(b) only prescription drugs meeting the federal Food and Drug Administration's safety, effectiveness, misbranding, adulteration and other standards shall be imported under the program;

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD03404-08-4

(c) only prescription drugs expected to generate substantial savings for consumers in the state shall be imported;

(d) the prescription drug is not:

(i) a controlled substance as defined in 21 U.S.C. § 802;

(ii) a biological product as defined in 42 U.S.C. § 262;

(iii) an infused drug, including a peritoneal dialysis solution;

(iv) an intravenously injected drug;

(v) a drug that is inhaled during surgery;

(vi) a drug which is a parenteral drug, the importation of which is determined by the United States Secretary of Health and Human Services to pose a threat to public health;

(e) any approved wholesaler shall at all times comply with the tracking and tracing requirements of 21 U.S.C. §§ 360eee and 360eee-1 to the extent practicable prior to imported prescription drugs coming into the possession of the approved wholesaler, and fully comply with those requirements after imported prescription drugs are in the possession of the approved wholesaler;

(f) an approved wholesaler shall not sell, distribute or dispense prescription drugs imported under the program outside of the state;

(g) the commissioner may impose an annual fee on approved wholesalers, which may be based in whole or in part on the value of prescription drugs imported by the approved wholesaler under the program, to support the operation of the program;

(h) every approved wholesaler shall provide the commissioner and the commissioner of education with information on its participation in the program as required by such commissioners including but not limited to:

(i) the name and quantity of the active ingredient of the drug;

(ii) a description of the dosage form of the drug;

(iii) the date on which the drug is received;

(iv) the quantity of the drug that is received;

(v) the point of origin and destination of the drug; and

(vi) the price paid by the approved wholesaler for the drug

(i) the commissioner shall provide for auditing of the program, including making sure that prescription drugs are made available at substantial savings to consumers as a result of the program, ensuring that the prescription drugs are approved for marketing in the United States, meet all labeling requirements under state and federal laws and regulations, and is not adulterated or misbranded, and ensuring that prescription drugs are authentic and in compliance with the federal Food and Drug Administration's approved drug specifications and standards.

3. The department, in consultation with the state education department, shall promulgate rules and regulations to design the program in accordance with subdivision two of this section.

4. (a) The commissioner, in consultation with the commissioner of education, shall seek all necessary approvals and certification by the secretary of the U.S. Department of Health and Human Services and/or other appropriate federal officials or agencies for the wholesale prescription drug importation program designed under this section.

(b) The commissioner shall seek the appropriate federal approvals, waivers, exemptions, or agreements, or a combination thereof, as needed to enable all covered entities enrolled in or eligible for the drug discount program authorized by section 340B of the federal public health service act (42 U.S.C. § 256b) to participate in the wholesale prescription drug importation program to the fullest extent possible without jeopardizing their eligibility for such drug discount program.

5. Upon receipt of federal approval and certification under paragraph (a) of subdivision four of this section, the commissioner shall implement the program pursuant to this section.

6. The commissioner shall immediately suspend the importation of a specific prescription drug or the importation of prescription drugs by an approved wholesaler if the commissioner discovers that any drug or activity is in violation of this section or any federal or state law or regulation, and shall immediately notify the commissioner of education of such suspension. Furthermore, the commissioner shall inform the commissioner of education of all facts and circumstances leading to such suspension as soon as practicable, and shall cooperate with the commissioner of education in any disciplinary investigation or action pursuant to title eight of the education law related to such wholesaler.

7. Nothing in this section shall be construed as affecting or in any way interfering with the commissioner of education's oversight of wholesalers.

8. The commissioner shall annually report to the governor, the temporary president of the senate, and the speaker of the assembly regarding the implementation of a federally approved wholesale prescription drug importation program. The report shall include, at a minimum:

(a) a list of the prescription drugs imported under the program;

(b) a list of all participating Canadian prescription drug suppliers, approved wholesalers, and other participating entities;

(c) estimated cost savings during the previous fiscal year;

(d) information regarding audit findings; and

(e) any other relevant information.

§ 2. Section 6808 of the education law is amended by adding a new subdivision 10 to read as follows:

10. Prescription drug importation program wholesalers. a. A wholesaler shall not participate in the wholesale prescription drug importation program under section two hundred eighty-d of the public health law without prior application and approval by the department.

b. Such application shall be made on a form prescribed by the department.

c. Such application shall be accompanied by a fee determined by the department.

d. All approvals shall be renewed on dates set by the department.

e. All approvals shall meet applicable federal laws and regulations including under 21 U.S.C. § 384, as amended, and any regulations promulgated thereunder.

§ 3. This act shall take effect eighteen months after it shall have become a law. Effective immediately, the addition, amendment and/or repeal of any rule or regulation necessary for the implementation of this act on its effective date are authorized to be made and completed on or before such effective date.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the public health law and the education law, in relation to creating a wholesale prescription drug importation program

Purpose

To create a state program to import prescription drugs from other coun- tries at lower cost.

Summary of provisions

Section one adds a new section 280-d to the Public Health Law to direct the Commissioner of Health, in consultation with the Commissioner of Education, to design a wholesale prescription drug importation program for the wholesale importation of prescription drugs from Canada. The prescription drugs imported under the program would be restricted to those that meet certain standards, including drugs that are expected to generate substantial savings for consumers in NY.

Under the bill, the Commissioner of Health would seek all necessary federal certifications and/or approvals for the program. The Department of Health would be authorized to impose annual fees on approved whole- salers to support the operation of the program. Additionally, the Department of Health would promulgate regulations in consultation with the State Education Department and report annually to the legislature.

Section two adds a new subdivision 10 to section 6808 of the Education Law to prohibit a wholesaler from participating in the wholesale drug importation program without prior application and approval by the State Education Department

Section three sets forth the effective date.

Justification

Concern about drug pricing is at an all-time high. Studies show how U.S. consumers pay the highest prices in the world for life-saving and enhancing drug treatments. The prices we pay may fund the research and development that benefits the entire world but those same prices make treatment options unavailable here at home if patients cannot afford their medicines or public programs cannot finance expensive treatments for everyone in need. Drug importation is high on the list of solutions the public wants to pursue.

Federal law allows the Secretary of Health and Human Services (HHS) to certify programs for personal and wholesale importation from countries such as Canada if consumer safety is on par with the U.S. drug supply chain system and significant consumer cost savings are realized.

Under the federal law, shipments from Canada, for example, will be test- ed on a sample basis for purity and potency and products would be labeled properly for the U.S. market and distributed to retail pharma- cies and other settings included in the program. Just as in the regular commercial market, retail pharmacies and other dispensing settings order and pay for products, and administrative costs set by the Commissioner. The product acquisition cost will be the Canadian price. Pharmacies and other dispensers will charge the Canadian price without mark-up, except for cost-based dispensing fee, for uninsured people or people in their deductible period. Health plans and other payers will pay dispensers for the product at the Canadian price without mark-up except for cost-based dispensing fee.

Medical care is a fundamental fact of life at some point or another, but the burden of paying for that care should not, on its own, be the death of us.

Legislative history

New bill

Fiscal implications

To be determined.

Effective date

This act shall take effect 18 months after it shall have become a law. Effective immediately, the addition, amendment and/or repeal of any rule or regulation necessary for the implementation of this act on its effec- tive date are authorized to be made and completed on or before such effective date.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.